ABOUT MYRIAD
OUR PRODUCTS
OUR RESEARCH
NEWS & EVENTS
INVESTOR RELATIONS
OUR CAREERS
OUR
RESEARCH
Research at Myriad
Drug Development Pipeline
Alzheimer's Disease
At-risk Population
Cost to Society
Patients & Caregivers
Brain Changes
Amyloid Hypothesis
Intervention Strategies
SALA
Links
References
Art & Alzheimer's
Flurizan™
Azixa™ (MPC-6827)
Vivecon™ (MPC-9055)
MPC-2130
MPC-0920
Clinical Trials
Selective Amyloid-beta 42 Lowering Agents (SALA)
Please note: You must have Flash Player installed to view this video. Download it for free
here
.
Read about SALAs - Selective Abeta2 Lowering Agents.
© 2008 Myriad Genetics, Inc.
